Willingness to receive a COVID-19 vaccine in people with multiple sclerosis - UK MS Register survey

Mult Scler Relat Disord. 2021 Oct:55:103175. doi: 10.1016/j.msard.2021.103175. Epub 2021 Jul 27.


Background & methods: We conducted an online COVID-19 survey as the vaccines became available, utilising the UK MS Register, to understand people with multiple sclerosis (pwMS) views on COVID-19 vaccination and the subsequent vaccine uptake rates.

Results & conclusion: 94.4% of 3191 pwMS surveyed indicated they would get a COVID-19 vaccine, while 5.6% would not. PwMS who have previously had an influenza vaccine, increasing age and the perception of having sufficient information about the vaccine were associated with increased likelihood of getting a vaccine. 51.7% of 3191 pwMS completed a follow-up survey indicating they received at least 1 dose of a COVID-19 vaccine. The proportion having had the vaccination based on their prior opinions was 53.2% in 'Yes' group and 27.0% in 'No' group, the latter reflecting a change based on their initial views. More information on COVID-19 vaccine safety in pwMS would be helpful for people to make informed decisions.

Keywords: Multiple sclerosis, COVID-19, vaccine; vaccination, UK MS Register.

Publication types

  • Letter

MeSH terms

  • COVID-19 Vaccines
  • COVID-19*
  • Humans
  • Influenza Vaccines*
  • Multiple Sclerosis*
  • SARS-CoV-2
  • United Kingdom
  • Vaccination


  • COVID-19 Vaccines
  • Influenza Vaccines